Leukemia

Leukemia, the most common cancer in children, is a hematological malignancy caused by clonal proliferation of abnormal lymphoid or hematopoietic cells in the bone marrow and/or lymphoid system. Leukemias can be classified into many subtypes based on cell of origin, clinical, phenotypic, and genetic...

Descrición completa

Gardado en:
Detalles Bibliográficos
Formato: Online
Idioma:inglés
Publicado: Exon Publications 2022
Subjects:
Acceso en liña:https://directory.doabooks.org/handle/20.500.12854/92985
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
_version_ 1869516937604628480
collection Directory of Open Access Books
description Leukemia, the most common cancer in children, is a hematological malignancy caused by clonal proliferation of abnormal lymphoid or hematopoietic cells in the bone marrow and/or lymphoid system. Leukemias can be classified into many subtypes based on cell of origin, clinical, phenotypic, and genetic information. Tremendous advances have been made in the leukemia field during the last several decades. Our understanding of the biology of different types of leukemia has significantly improved through a huge amount of basic and clinical research. The application of advanced diagnostic technologies has led to the identification of not only new leukemia subtypes but also the clinical outcomes of all leukemias. One classic example is pediatric acute lymphoblast leukemia, the most common fatal disease in children, which has become a highly curable disease with a curable rate of over 80%. The book Leukemia, written by an international team has covered many of these achievements. It provides the most up-to-date information on important topics such as the new 5th Edition of the World Health Organization Classification of hematolymphoid tumors, prognostic and predictive biomarkers, minimal residual disease, pharmacogenomics, diagnostic use of flow cytometry, and gives updates on several interesting leukemia entities such as infant leukemia, hairy cell leukemia, acute myeloid leukemia with myelodysplasia-related changes, secondary acute myeloid leukemia, and myeloid/lymphoid neoplasms with PDGFRA rearrangement. This book will be of great value to a wide audience seeking information in the leukemia field either for clinical purposes or research purposes.
format Online
id doab-20.500.12854ir-92985
institution Directory of Open Access Books
language eng
publishDate 2022
publishDateRange 2022
publishDateSort 2022
publisher Exon Publications
publisherStr Exon Publications
record_format ojs
spelling doab-20.500.12854ir-929852022-10-21T07:00:09Z Leukemia Li, Weijie leukemia hematolymphoid tumors infant leukemia hairy cell leukemia measurable residual disease in acute leukemia acute myeloid leukemia with myelodysplasia related changes secondary acute myeloid leukemia myeloid/lymphoid neoplasms PDGFRA rearrangement leukemia pharmacogenomics acute lymphoblastic leukemia MJCL Leukemia, the most common cancer in children, is a hematological malignancy caused by clonal proliferation of abnormal lymphoid or hematopoietic cells in the bone marrow and/or lymphoid system. Leukemias can be classified into many subtypes based on cell of origin, clinical, phenotypic, and genetic information. Tremendous advances have been made in the leukemia field during the last several decades. Our understanding of the biology of different types of leukemia has significantly improved through a huge amount of basic and clinical research. The application of advanced diagnostic technologies has led to the identification of not only new leukemia subtypes but also the clinical outcomes of all leukemias. One classic example is pediatric acute lymphoblast leukemia, the most common fatal disease in children, which has become a highly curable disease with a curable rate of over 80%. The book Leukemia, written by an international team has covered many of these achievements. It provides the most up-to-date information on important topics such as the new 5th Edition of the World Health Organization Classification of hematolymphoid tumors, prognostic and predictive biomarkers, minimal residual disease, pharmacogenomics, diagnostic use of flow cytometry, and gives updates on several interesting leukemia entities such as infant leukemia, hairy cell leukemia, acute myeloid leukemia with myelodysplasia-related changes, secondary acute myeloid leukemia, and myeloid/lymphoid neoplasms with PDGFRA rearrangement. This book will be of great value to a wide audience seeking information in the leukemia field either for clinical purposes or research purposes. Published 2022-10-21T07:00:05Z 2022-10-21T07:00:05Z 2022-10-16 book 978-0-6453320-7-0 https://directory.doabooks.org/handle/20.500.12854/92985 eng image/png Attribution-NonCommercial-NoDerivatives 4.0 International https://exonpublications.com/index.php/exon/issue/view/leukemia-open-access-book Exon Publications Electronic 10.36255/exon-publications-leukemia 10.36255/exon-publications-leukemia 2d6001a3-9e06-4979-bf02-6974e313eb24 978-0-6453320-7-0 Electronic Brisbane, Australia open access
spellingShingle leukemia
hematolymphoid tumors
infant leukemia
hairy cell leukemia
measurable residual disease in acute leukemia
acute myeloid leukemia with myelodysplasia related changes
secondary acute myeloid leukemia
myeloid/lymphoid neoplasms
PDGFRA rearrangement
leukemia pharmacogenomics
acute lymphoblastic leukemia
MJCL
Leukemia
title Leukemia
title_full Leukemia
title_fullStr Leukemia
title_full_unstemmed Leukemia
title_short Leukemia
title_sort leukemia
topic leukemia
hematolymphoid tumors
infant leukemia
hairy cell leukemia
measurable residual disease in acute leukemia
acute myeloid leukemia with myelodysplasia related changes
secondary acute myeloid leukemia
myeloid/lymphoid neoplasms
PDGFRA rearrangement
leukemia pharmacogenomics
acute lymphoblastic leukemia
MJCL
topic_facet leukemia
hematolymphoid tumors
infant leukemia
hairy cell leukemia
measurable residual disease in acute leukemia
acute myeloid leukemia with myelodysplasia related changes
secondary acute myeloid leukemia
myeloid/lymphoid neoplasms
PDGFRA rearrangement
leukemia pharmacogenomics
acute lymphoblastic leukemia
MJCL
url https://directory.doabooks.org/handle/20.500.12854/92985